Holdings

Bain Capital Life Sciences Investors, LLC

As of Sep 30, 2026, Bain Capital Life Sciences Investors, LLC reported 19 positions worth US$1.19B. Largest: Kailera Therapeutics, Inc., Heartflow, Inc. and ADARx Pharmaceuticals, Inc. What it bought and sold, with each filing.

CompanySharesValue as reportedChangeAs of
Kailera Therapeutics, Inc.22.6MUS$258Mno changeSep 30, 2026
Heartflow, Inc.4.45MUS$221M−4MSep 30, 2026
ADARx Pharmaceuticals, Inc.6.73MUS$134MnewSep 30, 2026
Savara, Inc.17.6MUS$90.8Mno changeSep 30, 2026
Tarsus Pharmaceuticals, Inc.1.1MUS$86.2MnewSep 30, 2026
Solid Biosciences Inc.9.81MUS$70.9Mno changeSep 30, 2026
Olema Pharmaceuticals, Inc.7.09MUS$61.2Mno changeSep 30, 2026
Hemab Therapeutics Holdings, Inc.1.65MUS$50.9Mno changeSep 30, 2026
Cabaletta Bio, Inc.21.2MUS$40.7M+3.97MSep 30, 2026
Freenome, Inc.2.37MUS$37.3MnewSep 30, 2026